celecoxib has been researched along with thromboxanes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Asfaha, S; McKnight, W; Muscará, MN; Wallace, JL | 1 |
| Bing, RJ; Karouni, K; Lomnicka, M; Sue, M; Wessel, LA | 1 |
| Ehnert, C; Geisslinger, G; Grösch, S; Manderscheid, C; Niederberger, E; Schmidt, H | 1 |
| Geisslinger, G; Graff, J; Harder, S; Klinkhardt, U; Nüsing, RM; Seyberth, H; Skarke, C; Watzer, B | 1 |
| Burgess, T; Chu, LM; Lassaletta, A; Liu, Y; Robich, MP; Sellke, FW; Sellke, N | 1 |
| Hjemdahl, P; Stiller, CO | 1 |
1 review(s) available for celecoxib and thromboxanes
| Article | Year |
|---|---|
Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Fibrinolytic Agents; Humans; Ibuprofen; Lactones; Naproxen; Prostaglandins; Prostaglandins I; Sulfones; Thromboxanes | 2022 |
1 trial(s) available for celecoxib and thromboxanes
| Article | Year |
|---|---|
Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.
Topics: Adult; Antigens, Neoplasm; Blood Platelets; Celecoxib; Cell Adhesion; Cyclic AMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Fibrinogen; Humans; Lactones; Leukocytes; Male; Naproxen; P-Selectin; Phospholipases A; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Prostaglandins; Pyrazoles; Reference Values; Sulfonamides; Sulfones; Thrombin; Thrombomodulin; Thromboxanes; Time Factors | 2007 |
4 other study(ies) available for celecoxib and thromboxanes
| Article | Year |
|---|---|
Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Celecoxib; Collagen; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Exudates and Transudates; Gastric Mucosa; Inflammation; Isoenzymes; Male; Membrane Proteins; Naproxen; Nitrates; Nitric Oxide Donors; Nitrites; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Thromboxanes; Wound Healing | 2000 |
Effects of nonsteroidal anti-inflammatory drugs on prostacyclin and thromboxane in the kidney.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Dose-Response Relationship, Drug; Drug Interactions; Epoprostenol; Kidney; Mercuric Chloride; Pyrazoles; Rabbits; Sulfonamides; Thromboxanes | 2003 |
Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
Topics: Apoptosis; Celecoxib; Cell Cycle; Cell Cycle Proteins; Cell Division; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelium, Vascular; Epoprostenol; Gene Expression; Humans; Isoenzymes; Lactones; Membrane Proteins; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Thromboxanes | 2004 |
Hypercholesterolemia and chronic ischemia alter myocardial responses to selective cyclooxygenase-2 inhibition.
Topics: Animals; Celecoxib; Comorbidity; Cyclooxygenase 2 Inhibitors; Epoprostenol; Heart; Hemodynamics; Humans; Hypercholesterolemia; Immunohistochemistry; Myocardial Contraction; Myocardial Ischemia; Oxidative Stress; Pyrazoles; Sulfonamides; Swine; Swine, Miniature; Thromboxanes; Ventricular Function, Left | 2011 |